Kerstin Andersson
ORCID: 0000-0001-6302-7006
· 5 papers in corpus
nonrandomized-trial
1999
OBJECTIVE: To determine the association between endometrial thickness and endometrial histology in a large sample of women using HRT. DESIGN: Results from three multi-centre studies were combined. PARTICIPANTS: Five hundred and sixty-four…
rct
1997
OBJECTIVE: To investigate the clinical effects especially with regard to histopathology and bleeding patterns by levonorgestrel (5- or 10 microg/24 h) released from an intrauterine system (IUS) in combination with estradiol valerate (2 mg) …
review
1997
Abstract Synthetic progestogens have been widely used in the treatment of heavy menstrual bleeding. The physiological background for this is the change of the endometrium which occurs after administration of progestogens indicative of endom…
other
1991
Treatment with flurbiprofen (100 mg twice a day for 5 days), tranexamic acid (1.5 gm three times a day for 3 days and 1 gm twice a day for another 2 days), and an intrauterine contraceptive device releasing 20 micrograms levonorgestrel per …
nonrandomized-trial
1976
The effects of the selective beta2-receptor stimulator terbutaline (0-25 to 0-5 mg given intravenously) on myometrial activity, local uterine blood flow, and lower abdominal pain were examined during the first day of menstruation in 11 wome…